Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             43 results found
no title author magazine year volume issue page(s) type
1 Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice Sun, Hong-Xiang
 2004
 22 29-30 p. 3882-3889
8 p.
 article
2 Association of antigens to ISCOMATRIX™ adjuvant using metal chelation leads to improved CTL responses Malliaros, Jim
 2004
 22 29-30 p. 3968-3975
8 p.
 article
3 A therapeutic HIV vaccine: how good is good enough? Walensky, Rochelle P.
 2004
 22 29-30 p. 4044-4053
10 p.
 article
4 Attempts to cure and prevent HIV/AIDS in central Nigeria between 1997 and 2002: opening a way to a vaccine-based solution to the problem? Abalaka, Jeremiah Ojonemi Alabi
 2004
 22 29-30 p. 3819-3828
10 p.
 article
5 Attenuated Salmonella typhimurium htrA mutants cause fatal infections in mice deficient in NADPH oxidase and destroy NADPH oxidase-deficient macrophage monolayers Mutunga, Mbithe
 2004
 22 29-30 p. 4124-4131
8 p.
 article
6 Bacillus Calmette-Guérin shares with virulent Mycobacterium tuberculosis the capacity to subvert monocyte differentiation into dendritic cell: implication for its efficacy as a vaccine preventing tuberculosis Gagliardi, Maria Cristina
 2004
 22 29-30 p. 3848-3857
10 p.
 article
7 Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli Nagaike, Kazuhiro
 2004
 22 29-30 p. 4069-4074
6 p.
 article
8 Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins Abraham, Jean-Daniel
 2004
 22 29-30 p. 3917-3928
12 p.
 article
9 Continuous antigenic stimulation system (CASS) as a new immunization strategy Gomez-Vargas, Andrew
 2004
 22 29-30 p. 3902-3910
9 p.
 article
10 Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain Plans-Rubió, Pedro
 2004
 22 29-30 p. 4002-4013
12 p.
 article
11 Differences in the immune response to long term Aβ vaccination in C57BL/6 and B6D2F1 mice Seabrook, Timothy J.
 2004
 22 29-30 p. 4075-4083
9 p.
 article
12 Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran Mohebali, Mehdi
 2004
 22 29-30 p. 4097-4100
4 p.
 article
13 Editorial Board/Aims and Scope 2004
 22 29-30 p. IFC-
1 p.
 article
14 Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters Jathoul, Amit P.
 2004
 22 29-30 p. 3942-3946
5 p.
 article
15 Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan Maitta, Robert W.
 2004
 22 29-30 p. 4062-4068
7 p.
 article
16 Enhancement of vaccine-specific cellular immunity in infants by passively acquired maternal antibody Rowe, J.
 2004
 22 29-30 p. 3986-3992
7 p.
 article
17 Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin Hsieh, Chia-Jung
 2004
 22 29-30 p. 3993-4001
9 p.
 article
18 Epidemiology of severe varicella–zoster virus infection in Spain Gil, Angel
 2004
 22 29-30 p. 3947-3951
5 p.
 article
19 Erratum to “Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model” [Vaccine 22 (2004) 1732–1743] Wild, Jens
 2004
 22 29-30 p. 4132-4133
2 p.
 article
20 Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines Daly, Janet M.
 2004
 22 29-30 p. 4101-4109
9 p.
 article
21 Evidence that use of an inactivated equine herpesvirus vaccine induces serum cytotoxicity affecting the equine arteritis virus neutralisation test Newton, J. Richard
 2004
 22 29-30 p. 4117-4123
7 p.
 article
22 Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule Christensen, Peer B.
 2004
 22 29-30 p. 3897-3901
5 p.
 article
23 Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children Kim, J.S.
 2004
 22 29-30 p. 3952-3962
11 p.
 article
24 Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins de Jonge, Marien I.
 2004
 22 29-30 p. 4021-4028
8 p.
 article
25 Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep Stanley, A.C.
 2004
 22 29-30 p. 3929-3941
13 p.
 article
26 Jerimiah Abalaka and HIV in Nigeria Spier, R.E.
 2004
 22 29-30 p. 3817-3818
2 p.
 article
27 Long-term effects of vaccination on attentional performance Nicoletti, Roberto
 2004
 22 29-30 p. 3877-3881
5 p.
 article
28 Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine Bogaert, D.
 2004
 22 29-30 p. 4014-4020
7 p.
 article
29 Need for re-appraisal of acute flaccid paralysis (AFP) case classification Paul, Y.
 2004
 22 29-30 p. 3829-3830
2 p.
 article
30 Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development Wu, Suh-Chin
 2004
 22 29-30 p. 3858-3864
7 p.
 article
31 Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP142 formulated with novel adjuvants or with alum Pichyangkul, Sathit
 2004
 22 29-30 p. 3831-3840
10 p.
 article
32 Prevention of viral hepatitis in Italy FitzSimons, David
 2004
 22 29-30 p. 4092-4096
5 p.
 article
33 Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine Guo, Ying-jun
 2004
 22 29-30 p. 3841-3847
7 p.
 article
34 Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host Martinez, Isidoro
 2004
 22 29-30 p. 4035-4043
9 p.
 article
35 Reducing methane emissions in sheep by immunization against rumen methanogens Wright, A.D.G.
 2004
 22 29-30 p. 3976-3985
10 p.
 article
36 Safety concerns regarding combination vaccines: the experience in Japan Andreae, Margie C.
 2004
 22 29-30 p. 3911-3916
6 p.
 article
37 Surveillance of congenital rubella syndrome in Japan, 1978–2002: effect of revision of the immunization law Katow, Shigetaka
 2004
 22 29-30 p. 4084-4091
8 p.
 article
38 The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients Kara, Ismail Hamdi
 2004
 22 29-30 p. 3963-3967
5 p.
 article
39 Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccines Brandileone, Maria Cristina C.
 2004
 22 29-30 p. 3890-3896
7 p.
 article
40 Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund’s adjuvant induced partial protection against challenge Klingström, Jonas
 2004
 22 29-30 p. 4029-4034
6 p.
 article
41 Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii Johnson, Lawrence L.
 2004
 22 29-30 p. 4054-4061
8 p.
 article
42 Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis Iborra, Salvador
 2004
 22 29-30 p. 3865-3876
12 p.
 article
43 Waning immunity and subclinical measles infections in England Glass, K.
 2004
 22 29-30 p. 4110-4116
7 p.
 article
                             43 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands